Aspire Biopharma Holdings, Inc. Common Stock
Symbol: ASBP (NASDAQ)
0.32
▲ (0.32%) 0.001
Company Description:
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.
Key Stats
- Today's Open: $0.315
- Today's High: $0.317
- Today's Low: $0.315
- Today's Volume: 2.84K
- Yesterday Close: $0.315
- Yesterday High: $0.3331
- Yesterday Low: $0.305
- Yesterday Volume: 1.97M
- Last Min Volume: 18
- Last Min High: $0.316
- Last Min Low: $0.316
- Last Min VWAP: $0.316
Company Profile
- Name: Aspire Biopharma Holdings, Inc. Common Stock
- Website: https://www.aspirebiolabs.com
- Listed Date: 2025-02-20
- Location: HUMACAO, PR
- Market Status: Active
- CIK Number: 0001847345
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $15.60M
- Round Lot: 100
- Outstanding Shares: 49.53M
- Asset Type: CS
RECENT FILINGS FOR ASBP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-17 | 8-K | View |
| 2025-09-29 | EFFECT | View |
| 2025-09-26 | S-1/A | View |
| 2025-09-26 | 8-K | View |
| 2025-09-23 | DEF 14A | View |
| 2025-09-18 | S-1 | View |
| 2025-09-08 | PRE 14A | View |
| 2025-08-22 | 8-K | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 10-Q/A | View |
| 2025-07-30 | 8-K | View |
| 2025-06-18 | 8-K | View |
| 2025-06-10 | 4/A | View |
| 2025-06-10 | 8-K | View |
| 2025-06-06 | 4 | View |
| 2025-05-29 | EFFECT | View |
| 2025-05-28 | CORRESP | View |
| 2025-05-20 | UPLOAD | View |
| 2025-05-19 | SCHEDULE 13G/A | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
Latest News on ASBP